Recent Publications
Proteomics
Congrats to Mikko Taipale and his team for their Cell paper where they conducted high-content screens to show widespread protein mislocalization in diverse human disorders. NBCC contributions from Zhen-Yuan Lin (proteomics, pictured).
September 30, 2024
Screening
Congrats to Ben Blencowe and colleagues for their Nature Communications paper describing a high-throughput screen to identify modulators of neuronal microexons whose splicing is often misregulated in autism. NBCC contributions from the high-throughput screening facility (Mark Jen, pictured).
July 27, 2024
Multi-Facility
Congrats to Daniel Schramek and colleagues for their Nature Communications paper identifying SCAF1 & USP15 as drivers of pancreatic cancer through in vivo CRISPR screens. NBCC contributions from the sequencing (Kin Chan & Angeline Zhang, pictured) and flow cytometry facilities.
June 20, 2024
Proteomics
Congrats to John Rubinstein and colleagues for their Science paper where they used single-particle electron microscopy to obtain a high-resolution structure of V-ATPase within the native synaptic vesicle membrane. NBCC contributions from Cassandra Wong (pictured) and Brendon Seale in Proteomics.
June 20, 2024
Multi-Facility
Congrats to the Schramek lab on their paper in Molecular Systems Biology using genome-wide CRISPR screening to identify regulators of p53 stability. NBCC contributions from Mike Parsons (Flow), (pictured), Kin Chan (NGS) and Zhen-Yuan Lin (proteomics).
June 10, 2024
Screening & Serology
Congrats to Jen Gommerman and colleagues for their work supporting the need for intranasal COVID-19 vaccines in their Mucosal Immunology paper looking at breakthrough infections and vaccination. NBCC contributions from the serology team and high-throughput screening facility. (Melanie Delgado Brand, pictured)
April 17, 2024
Proteomics
Congrats to Mikko Taipale and colleagues for their paper in Nature identifying proteins involved in protein stabilization or degradation. NBCC contributions from Cassandra Wong (proteomics).
March 20, 2024
Network Biology Collaborative Centre Publications by the Numbers:
January 1, 2011 to August 16, 2024
| Total Publications | 475 |
| Total in 2024 | 29 |
| Total Citations | 44,561 |
| H-index | 101 |
List of Publications since 2011.
How to Cite
Being acknowledged in publications is important for the long-term sustainability of the NBCC as it is a key funding metric and allows us to fulfill reporting requirements of granting agencies. How the NBCC gets acknowledged will vary for each individual project.
As a guideline, routine analysis that involves technical skill but no development of new methodology or interpretation of data does not constitute authorship but should be mentioned in the acknowledgement and/or methods section.
Authorship is recommended, according to scientific custom, when the staff member makes a substantial contribution to a paper such as helping to conceive or design the project, providing input critical to the direction of the project, developing advanced techniques for acquiring or analyzing data, and helping to draft or revise the paper (beyond the materials and methods) for intellectual content. Authorship for staff, when warranted, properly recognizes their intellectual contribution to a manuscript and is important for their career advancement.
For further reading, the Association of Biomolecular Resource Facilities (ABRF) has published authorship guidelines for core facility staff.
Suggested acknowledgement for each facility:
| Facility | Acknowledgement |
|---|---|
| Proteomics | The authors wish to thank [staff name] of the Network Biology Collaborative Centre Proteomics Facility (RRID: SCR_025375) at the Lunenfeld-Tanenbaum Research Institute for [service]. The facility is supported by the Canada Foundation for Innovation and the Ontario Government. |
| Next-Generation Sequencing | The authors wish to thank [staff name] of the Network Biology Collaborative Centre Next-Generation Sequencing Facility (RRID: SCR_025385) at the Lunenfeld-Tanenbaum Research Institute for [service]. The facility is supported by the Canada Foundation for Innovation and the Ontario Government. |
| High-Throughput Screening | The authors wish to thank [staff name] of the Network Biology Collaborative Centre High-Throughput Screening Facility (RRID: SCR_025390) at the Lunenfeld-Tanenbaum Research Institute for [service]. The facility is supported by the Canada Foundation for Innovation and the Ontario Government. |
| High-Content Screening | The authors wish to thank [staff name] of the Network Biology Collaborative Centre High-Content Screening Facility (RRID: SCR_025391) at the Lunenfeld-Tanenbaum Research Institute for [service]. The facility is supported by the Canada Foundation for Innovation and the Ontario Government. |
| Advanced Imaging | The authors wish to thank [staff name] of the Network Biology Collaborative Centre Advanced Imaging Facility (RRID: SCR_025389) at the Lunenfeld-Tanenbaum Research Institute for [service]. The facility is supported by the Canada Foundation for Innovation and the Ontario Government. |
| Flow Cytometry | The authors wish to thank [staff name] of the Network Biology Collaborative Centre Flow Cytometry Facility (RRID: SCR_025384) at the Lunenfeld-Tanenbaum Research Institute for [service]. The facility is supported by the Canada Foundation for Innovation and the Ontario Government. |